Efficacy and safety of ticagrelor and clopidogrel among Chinese patients for elective percutaneous coronary intervention

Trial Profile

Efficacy and safety of ticagrelor and clopidogrel among Chinese patients for elective percutaneous coronary intervention

Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 May 2017 New trial record
    • 06 Apr 2017 Results published in the International Heart Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top